Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Filing Type:

Year:

Date	Form	Description	Pages
04/06/20	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	1
04/06/20	POS AM	Post-effective amendment to a registration statement that is not immediately effective upon filing Documents expand_more EX-23.1	39
04/02/20	UPLOAD	SEC-generated letter Documents expand_more TEXT-EXTRACT	1
04/02/20	6-K/A	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1 EX-99.2 EX-99.3	14
04/01/20	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1 EX-99.2 EX-99.3	14
03/30/20	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	6
03/27/20	F-1	Registration statement for securities of certain foreign private issuers Documents expand_more EX-5.1 EX-23.1	56
03/27/20	POS AM	Post-effective amendment to a registration statement that is not immediately effective upon filing Documents expand_more EX-23.1	39
03/27/20	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-2.1 EX-4.23 EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	212
03/27/20	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	12